FEATURES OF THE PSYCHOSOMATIC STATE IN PATIENTS WITH CHRONIC HEART FAILURE AND COVID-19



Cite item

Full Text

Abstract

Background: The comorbidity of CHF with COVID-19, isolation mode, and increased stress situation increase the number of cases of anxiety and depressive disorders, contribute to the deterioration of the course of the underlying disease, and increase the risk of fatal cardiovascular-vascular events.

Materials and methods: In 2022-2023, 1940 outpatient medical records were retrospectively analyzed.

Results: The incidence of coronavirus infection COVID-19 changes the psychosomatic state of patients with CHF, increasing the severity of anxiety and aggravating depressive symptoms.

 Conclusion: The data obtained in our study on changes in the psychosomatic state of patients with CHF against the background of coronavirus infection emphasize the need for an integrated approach to treatment, including mental health support

Full Text

Restricted Access

About the authors

Zhannat Nurmakhanova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: zhanna12932@mil.ru
ORCID iD: 0000-0002-6528-7060

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Gulbanu Abdugulova

Kazakh National Medical University named after S.D. Asfendiyarov

Author for correspondence.
Email: a.gulbany@mail.ru
ORCID iD: 0000-0001-8832-9705

Master of Medicine, Assistant of the Department of General Medical Practice No. 1, School of General Medicine 2

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Zulfiya Zhankalova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: zulfiya-zhankalo@mail.ru
ORCID iD: 0000-0002-5122-4130

доктор медицинских наук, профессор, кафедра общей врачебной практики №1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Akmaral Abdykulova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: akmaral_abd@mail.ru
ORCID iD: 0000-0002-0330-6764

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Gulzhan Gabdulina

Kazakh National Medical University named after S.D. Asfendiyarov

Email: gabdulina.g@kaznmu.kz
ORCID iD: 0000-0001-5536-6227

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Aigul Tazhiyeva

Kazakh National Medical University named after S.D. Asfendiyarov

Email: a.tazhiyeva@mail.ru
ORCID iD: 0000-0002-3674-0321

Doctor of Medical Sciences, Head of the Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Venera Khabizhanova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: habizhanova.v@kaznmu.kz
ORCID iD: 0000-0002-7488-0173

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Indira Omarova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: indiraomarova.kz1989@gmail.com
ORCID iD: 0000-0001-8312-0558

Master of Medical Sciences, Doctoral Student of the Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Zoya Yensegenova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: zoyazhar@mail.ru
ORCID iD: 0009-0008-9934-9523

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Elmira Yerenchina

Kazakh National Medical University named after S.D. Asfendiyarov

Email: elmira_er@mail.ru
ORCID iD: 0000-0002-4318-2946

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Raushan Kassymova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: rau-nur@mail.ru
ORCID iD: 0000-0002-0845-9794

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Kaldygul Kushimbaeva

Kazakh National Medical University named after S.D. Asfendiyarov

Email: kalda77@mail.ru
ORCID iD: 0009-0004-2386-4028

Master of Medical Sciences, Assistant of the Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Marzhan Matchanova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: maka130773@mail.ru
ORCID iD: 0009-0002-6979-899X

Candidate of Medical Sciences,  Associate Professor, Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Aigul Erlepessova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: aigul.a_84@mail.ru
ORCID iD: 0009-0009-6882-3605

Assistant of the Department of General Medical Practice No1

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

Aizhzmal Yessirkepova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: aizhamal-65@mail.ru
ORCID iD: 0000-0003-2991-8651

Master of Medicine, Assistant of the Department of General Medical Practice No1

Kazakhstan, A05H2A6, Kazakhstan, Almaty, Tole bi Street, 94

Madina Zhaparkulova

Kazakh National Medical University named after S.D. Asfendiyarov

Email: mediksun@mail.ru
ORCID iD: 0009-0009-7795-0657

Master of Medicine, Assistant of the Department of General Medical Practice No1

Kazakhstan, A05H2A6, Kazakhstan, Almaty, Tole bi Street, 94

Svetlana Tuleutayeva

Kazakh National Medical University named after S.D. Asfendiyarov

Email: maxataul@mail.ru
ORCID iD: 0000-0002-9287-0454

Master of Medicine, Assistant of the Department of General Medical Practice No1

 

Kazakhstan, A05H2A6 Kazakhstan, Almaty, Tole bi Street, 94

References

  1. Chazova I.E., Mironova O.Y. COVID-19 and cardiovascular diseases. Therapeutic archive. 9,2020. DOI: 10.2644200403660.2020.09.000742.
  2. Bubnova M.G., Aronov D.M. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation. Pulmonology.2020,30(5):688-699
  3. Sergienko E.A. Psychological Health: Subjective Factors. Institute of Psychology of the Russian Academy of Sciences. - 2017. (2):1-9.
  4. Kozlov I.A., Tyurin I.N. Cardiovascular complications of COVID-19. Bulletin of Anesthesiology and Resuscitation. 2020; 17(4):14-22.
  5. Shlyakhto E.V., Konradi A.O., Arutyunov A.G. Rukovodstvo po diagnostike i lecheniyu zabolevanii sistemy kruobrazheniya v kontekste pandemici COVID-19 [A guide to the diagnosis and treatment of diseases of the blood circulation system in the context of the COVID-19 pandemic]. Russian Journal of Cardiology. 2020; 25(3):4-20.
  6. Barbarash O.L., Karetnikova V.N., Kashtalap V.V. Novaya Koronavirusnaya boleznosti (COVID-19) i Kartsional'nye zabolevaniye [New coronavirus disease (COVID-19) and cardiovascular diseases]. Complex Problems of Cardiovascular Diseases.2020; 9(2):17-28.
  7. Gromova O.A., Torshin I.Yu., Gabdulina G.Kh. COVID-19 Pandemic: Protective Roles of Vitamin D
  8. Polonskaya Ya.V., Kashtanova E.V., Stakhneva E.M., Sadovodsky E.V., Ragino YU.I. COVID-19 and cardiovascular diseases. Journal of Atherosclerosis. 2020.(2).73-79.
  9. mhGAP-IG Guidelines for Providing Care for Mental and Neurological Substance Use Disorders in Non-Specialized Health Care Settings. Version 2.0. World Health Organization, Regional Office for Europe, 2018. https://creativecommons.org/licenses/by-nc-sa/3.0/igo.
  10. Course of CHF in patients who have had COVID-19. Eurasian Association of Therapists.2020https://euat.ru/publications/techenie_hsn_u_patsientov_perenesshih_ covid_19
  11. Chen C, Zhou Y, Wang DW. ARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; Mar 5. doi: 10.1007/s00059-020-04909-z
  12. Elkind MS, Harrington RA, Benjamin IJ. Role of the American Heart Association in the Global COVID-19 Pandemic. Circulation. 2020 Mar 17. doi: 10.1161/Circulationaha.120.046749.
  13. Petrova N.N. Comorbid Mental Disorders as a Factor in the Effectiveness of Treatment and Rehabilitation Measures in Cardiac Patients.Bulletin of the All-Union Scientific Center of the Siberian Branch of the Russian Academy of Medical Sciences.2016.Vol 1, No6 (112):88-91
  14. Clinical protocol for diagnosis and treatment of the Ministry of Health of the Republic of Kazakhstan. Chronic heart failure, 2018 https://diseases.medelement.com
  15. Shcherbatykh Y.V. Methods of diagnosing anxiety and anxiety – comparative assessment // Bulletin on Pedagogy and Psychology of Southern Siberia. 2021. №2. Available at: https://cyberleninka.ru/article/n/metodiki-diagnostiki-trevogi-i-trevozhnosti-sravnitelnaya-otsenka (accessed: 06.10.2024).
  16. Elshansky S.P., Anufriev A.F., Efimova O.S., Semenov D.V. Osobennosti retestovoy nadezhnosti shkali depressii A. Beka [Features of retest reliability of A. Bek's depression scale]. 2016. № 4. URL: https://psychology.snauka.ru/2016/04/6649.
  17. Roshchina OV, Simutkin GG, Bokhan NA, Surovtseva AK. The level of social adaptation and its relationship with the main clinical, dynamic and psychological characteristics in comorbidity of affective disorders and alcohol dependence. Neurology, neuropsychiatry, psychosomatics. 2022; 14(3):32–37. doi: 10.14412/2074-2711-2022-3-32-37.
  18. Russian Cardiology Bulletin 2021, Vol. 16, supplement A. A. Karaseva, A. D. Khudiakova, E. V. Garbuzova, Yu. I. Ragino, I. I. Logvinenko. The Russian Archives of Internal Medicine, 2024; 613:422; doi: 10.20514/2226-6704-2023-13-6-422-435
  19. Zuin M, Rigatelli G, Roncon L, et al. Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis. Heart Fail Rev. 2022:1-6. https://doi.org/10.1007/s10741-022-10292-0.
  20. Luo M., Guo L., Yu M., Jiang W. et al. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public - a systematic review and meta-analysis. Psychiatry Res. 2020; 291

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.